Can I go back to Trenvir (efavirenz-based ART) in Reydin (dolutegravir-based) is difficult?
25 April 2022. Related: All topics, Changing treatment, Side effects, Southern Africa. 6 comments
25 April 2022. Related: All topics, Changing treatment, Side effects, Southern Africa. 6 comments
24 April 2022. Related: All topics, COVID-19.
23 April 2022. Related: All topics, Support.
22 April 2022. Related: All topics, CD4 and viral load, Opportunistic infections, Starting treatment.
22 April 2022. Related: All topics, CD4 and viral load, Opportunistic infections, Starting treatment. 4 comments
21 April 2022. Related: All topics, PEP/PEPSE.
21 April 2022. Related: All topics, CD4 and viral load, Newly diagnosed, Starting treatment. 3 comments
20 April 2022. Related: All topics, CD4 and viral load.
20 April 2022. Related: All topics, HIV transmission, PrEP, Support.
19 April 2022. Related: All topics, HIV testing, HIV transmission, PEP/PEPSE, PrEP.
19 April 2022. Related: All topics, HIV testing, HIV transmission, PrEP.
19 April 2022. Related: All topics, Support, Travel.
19 April 2022. Related: All topics, HIV transmission, Sero different couples.
18 April 2022. Related: Adherence, All topics, Children, Southern Africa.
18 April 2022. Related: Adherence, All topics, Resistance. 6 comments
17 April 2022. Related: All topics, CD4 and viral load.
17 April 2022. Related: All topics, HIV transmission, PEP/PEPSE.
16 April 2022. Related: All topics, HIV transmission, PrEP.
15 April 2022. Related: All topics, Pregnancy. 22 comments
15 April 2022. Related: All topics, Changing treatment, HIV transmission.